E-LIB Suche - Ergebnisse für: Trinh, Roger

1

Glecaprevir/pibrentasvir for 8 weeks in treatment-naïve pat..:

Brown Jr, Robert S. ; Buti, Maria ; Rodrigues, Lino...
Journal of Hepatology. 72 (2020) 3 - p. 441-449 , 2020

Link: https://doi.org/10.1016/..

2

Efficacy and Safety of 8 Weeks of Glecaprevir/Pibrentasvir ..:

Fontana, Robert J. ; Lens, Sabela ; McPherson, Stuart...
Advances in Therapy. 36 (2019) 12 - p. 3458-3470 , 2019

Link: https://doi.org/10.1007/..

3

Efficacy and safety of ombitasvir/paritaprevir/ritonavir an..:

Poordad, Fred ; Sedghi, Shahriar ; Pockros, Paul J....
Journal of Viral Hepatitis. 26 (2019) 8 - p. 1027-1030 , 2019

Link: https://doi.org/10.1111/..

4

Safety and efficacy of glecaprevir/pibrentasvir for the tre..:

Foster, Graham R. ; Asselah, Tarik ; Kopecky-Bromberg, Sarah...
PLOS ONE. 14 (2019) 1 - p. e0208506 , 2019

Link: https://doi.org/10.1371/..

5

1965. Safety and Efficacy of Glecaprevir/Pibrentasvir in Pa..:

Rockstroh, Jurgen K ; Bhagani, Sanjay R ; Orkin, Chloe...
Open Forum Infectious Diseases. 5 (2018) suppl_1 - p. S569-S570 , 2018

Link: https://doi.org/10.1093/..

6

Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Trans..:

Reau, Nancy ; Kwo, Paul Y. ; Rhee, Susan...
Hepatology. 68 (2018) 4 - p. 1298-1307 , 2018

Link: https://doi.org/10.1002/..

7

Glecaprevir/Pibrentasvir in patients with chronic HCV genot..:

Flamm, Steven ; Mutimer, David ; Asatryan, Armen...
Journal of Viral Hepatitis. 26 (2018) 3 - p. 337-349 , 2018

Link: https://doi.org/10.1111/..

8

Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients..:

Rockstroh, Jürgen K ; Lacombe, Karine ; Viani, Rolando M...
Clinical Infectious Diseases. 67 (2018) 7 - p. 1010-1017 , 2018

Link: https://doi.org/10.1093/..

9

A Phase 1 Study to Evaluate the Effect of Crushing, Cutting..:

Oberoi, Rajneet K. ; Zhao, Weihan ; Sidhu, Dilraj S....
Journal of Pharmaceutical Sciences. 107 (2018) 6 - p. 1724-1730 , 2018

Link: https://doi.org/10.1016/..

10

TURQUOISE-I Part 1b: Ombitasvir/Paritaprevir/Ritonavir and ..:

Wyles, David ; Saag, Michael ; Viani, Rolando M....
The Journal of Infectious Diseases. 215 (2017) 4 - p. 599-605 , 2017

Link: http://www.jstor.org/sta..

11

TURQUOISE-I Part 1b: Ombitasvir/Paritaprevir/Ritonavir and ..:

Wyles, David ; Saag, Michael ; Viani, Rolando M....
The Journal of Infectious Diseases. 215 (2017) 4 - p. 599-605 , 2017

Link: https://doi.org/10.1093/..

12

Safety and Efficacy of Ombitasvir, Paritaprevir With Ritona..:

Rockstroh, Jürgen K ; Orkin, Chloe ; Viani, Rolando M...
Open Forum Infectious Diseases. 4 (2017) 3 - p. , 2017

Link: https://doi.org/10.1093/..

13

Sustained virologic response of 100% in HCV genotype 1b pat..:

Feld, Jordan J. ; Moreno, Christophe ; Trinh, Roger...
Journal of Hepatology. 64 (2016) 2 - p. 301-307 , 2016

Link: https://doi.org/10.1016/..

14

Evaluation of Drug-Drug Interactions Between Hepatitis C An..:

Khatri, Amit ; Dutta, Sandeep ; Wang, Haoyu...
Clinical Infectious Diseases. 62 (2016) 8 - p. 972-979 , 2016

Link: https://www.jstor.org/st..

15

Evaluation of Drug-Drug Interactions Between Hepatitis C An..:

Khatri, Amit ; Dutta, Sandeep ; Wang, Haoyu...
Clinical Infectious Diseases. 62 (2016) 8 - p. 972-979 , 2016

Link: https://doi.org/10.1093/..